Visby Medical Stock
PCR-Based Medical Testing
Sign up today and learn more about Visby Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Visby Medical Stock
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.
Investors
Plug and Play Tech Centre
Rappi, Flutterwave, Blockdaemon, FiscalNote, BigID, Shippo, Onfido, Heal, Credit Sesame, Visby Medical
Biomedical Advanced Research and Development Authority (BARDA)
Artiman Ventures
Valo Ventures
J Ventures
Funding History
| December 2012 | $6.0M |
|---|---|
| January 2018 | $9.5M |
| April 2019 | $100M |
| February 2021 | $12.3M |
Management
Chief Executive Officer
Adam de la Zerda
Chief Financial Officer
Mark Ibison
Press
patents - Apr, 15 2024
Molecular diagnostic devices and methods for retaining and mixing reagentspatents - Apr, 15 2024
Portable molecular diagnostic device and methods for the detection of target …patents - Apr, 15 2024
Devices and methods for nucleic acid extractionpatents - Apr, 15 2024
Devices and methods for nucleic acid extractionpatents - Apr, 15 2024
Devices and methods for antibiotic susceptability testingEquityZen Recognized As:
